These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 15027117)
1. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117 [TBL] [Abstract][Full Text] [Related]
2. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337 [TBL] [Abstract][Full Text] [Related]
3. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Yau WL; Lung HL; Zabarovsky ER; Lerman MI; Sham JS; Chua DT; Tsao SW; Stanbridge EJ; Lung ML Int J Cancer; 2006 Dec; 119(12):2821-6. PubMed ID: 16929489 [TBL] [Abstract][Full Text] [Related]
4. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Ji L; Nishizaki M; Gao B; Burbee D; Kondo M; Kamibayashi C; Xu K; Yen N; Atkinson EN; Fang B; Lerman MI; Roth JA; Minna JD Cancer Res; 2002 May; 62(9):2715-20. PubMed ID: 11980673 [TBL] [Abstract][Full Text] [Related]
5. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757 [TBL] [Abstract][Full Text] [Related]
6. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li J; Kashuba V; Klein G; Zabarovsky ER Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7504-9. PubMed ID: 11390984 [TBL] [Abstract][Full Text] [Related]
7. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma]. Liu XQ; Pan ZG; Li MZ; Jiang JH; Fu J; Long QX; Wang XZ; Zeng YX Ai Zheng; 2003 Feb; 22(2):128-35. PubMed ID: 12600284 [TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma. Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745 [TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209 [TBL] [Abstract][Full Text] [Related]
12. Expression of RASSF1A gene in nasopharyngeal carcinoma. Peng H; Zhao T; Yao KT Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):673-6. PubMed ID: 12865217 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680 [TBL] [Abstract][Full Text] [Related]
14. Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. Chow LS; Lam CW; Chan SY; Tsao SW; To KF; Tong SF; Hung WK; Dammann R; Huang DP; Lo KW Oncogene; 2006 Jan; 25(2):310-6. PubMed ID: 16116475 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521 [TBL] [Abstract][Full Text] [Related]
16. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of suppressive role of RASSF1A gene at 3p21.3 in lung cancer cell line A549]. Zhang S; Shao K; Zhang CY; Zhou F; Wang W; Xiong MH; He J Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):908-11. PubMed ID: 16029530 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896 [TBL] [Abstract][Full Text] [Related]
19. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma. Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089 [TBL] [Abstract][Full Text] [Related]
20. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman MI; Minna JD Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]